Salivary Glands



Salivary Glands






1.1 ACINIC CELL CARCINOMA VS. MAMMARY ANALOGUE SECRETORY CARCINOMA (MASC)

















































Acinic Cell Carcinoma


Mammary Analogue Secretory Carcinoma (MASC)


Age


Wide range, with slight peak in seventh decade. Slight female predominance


Usually adults, mean 47 years


Location


Parotid gland (90%), submandibular gland (5%), and minor salivary glands (5%)


Parotid (70%), oral cavity (20%), and submandibular gland (5%)


Symptoms


Painless, slow-growing mass


Painless, slow-growing mass


Signs


Generally well-circumscribed mass, sometimes with cystic features


Generally well-circumscribed mass, sometimes with cystic features


Etiology


Unknown


Unknown


Histology




  1. Diagnostic feature is the serous acinar cell, a medium-to-large polygonal cell with blue-purple cytoplasmic granules (zymogen granules) (Fig. 1.1.1). The number of serous acinar cells is variable



  2. Numerous additional cell types may be seen, including intercalated ductlike cells, vacuolated cells, clear cells, and nonspecific glandular cells (Fig. 1.1.2)



  3. Numerous growth patterns can be seen, including solid, microcystic, papillary-cystic, and follicular (Figs. 1.1.3 and 1.1.4)



  4. Secretory material within microcystic spaces may be seen occasionally



  5. Often well circumscribed but may be infiltrative



  6. Perineural invasion, necrosis, and elevated mitotic rates are not typical but are encountered in cases showing “highgrade transformation”




  1. No serous acinar cells



  2. Growth patterns overlap with acinic cell carcinoma. Microcystic is most common, but follicular, papillary-cystic, and solid patterns can be seen as well (Figs. 1.1.6, 1.1.7, and 1.1.8)



  3. Cells have apocrine features including abundant eosinophilic granular cytoplasm and a large nucleus with a prominent nucleolus (Fig. 1.1.9)



  4. Eosinophilic secretions are seen within the glandular spaces (Figs. 1.1.6, 1.1.7, and 1.1.9)



  5. May be infiltrative or well circumscribed



  6. Perineural invasion, necrosis, and elevated mitotic rates are not seen except in rare cases of high-grade transformation


Special studies




  • Positive for DOG-1 and usually negative for S100, mammaglobin, and GATA3 (Fig. 1.1.5)



  • Negative for ETV6 translocation




  • Positive for S100, mammaglobin, and GATA3 (Figs. 1.1.10 and 1.1.11). Staining for DOG-1 is usually negative



  • Positive for ETV6 translocation (usually with partner gene NTRK3) similar to secretory carcinoma of the breast (Fig. 1.1.12)


Treatment


Surgery only, except in those rare cases showing high-grade transformation


Therapy is not well standardized. Most have been treated with surgery, with a subset receiving radiotherapy as well. For rare aggressive cases, targeted therapies (tyrosine kinase inhibitors) may be of value


Prognosis


Good, with 10-year survival >90%


Appears to be similar to acinic cell carcinoma








Figure 1.1.1 Acinic cell carcinoma with a solid proliferation of serous acinar cells that contain numerous blue-purple granules in their cytoplasm.






Figure 1.1.2 Acinic cell carcinomas may show a combination of cell types including serous acinar cells, vacuolated cells, clear cells, and nonspecific glandular cells.






Figure 1.1.3 Acinic cell carcinoma demonstrating a mixture of solid, microcystic, and follicular growth patterns.






Figure 1.1.4 Acinic cell demonstrating a papillary-cystic growth pattern.






Figure 1.1.5 Acinic cell is consistently positive for DOG-1 in a membranous, canalicular-type distribution.






Figure 1.1.6 Mammary analogue secretory carcinoma exhibiting microcystic growth. This is the most common growth pattern of mammary analogue secretory carcinoma.







Figure 1.1.7 Mammary analogue secretory carcinoma with a follicular growth pattern. With the colloid-like eosinophilic secretions, the tumor mimics thyroid tissue.






Figure 1.1.8 Mammary analogue secretory carcinoma with papillary cystic growth.






Figure 1.1.9 Mammary analogue secretory carcinoma is comprised of a uniform population of cells with an abundant, eosinophilic cytoplasm. The nucleus is large and round to oval and has a visible nucleolus.






Figure 1.1.10 Mammary analogue secretory carcinoma is consistently positive for S100.






Figure 1.1.11 Mammary analogue secretory carcinoma is consistently positive for mammaglobin.






Figure 1.1.12 Mammary analogue secretory carcinoma harbors translocations for ETv6. In this break apart FISH assay, one copy of the ETv6 gene is intact (red and green signals together) and one is rearranged (red and green signals apart).



1.2 ADENOID CYSTIC CARCINOMA VS. EPITHELIAL-MYOEPITHELIAL CARCINOMA


















































Adenoid Cystic Carcinoma


Epithelial-Myoepithelial Carcinoma


Age


Typically adults, peak incidence in sixth decade


Typically adults, peak incidence in sixth to seventh decades


Location


Parotid gland is most common (40%-50%) but may arise in any major or minor salivary gland


Usually parotid gland (up to 80%) and uncommonly submandibular gland or minor salivary glands


Symptoms


Slow-growing swelling sometimes pain or paralysis due to perineural invasion. Other site-specific symptoms in minor salivary locations (e.g., nasal obstruction or epistaxis for sinonasal tumors)


Slowly growing, painless mass


Signs


Palpable nodules that may become fixed to surrounding tissues


Typically circumscribed, small mass. May be grossly cystic


Etiology


Unknown


Unknown


Histology




  1. Variable mixture of tubules, cribriform structures, and solid nests (Fig. 1.2.1)



  2. Cribriform pattern is most common, with cylindromatous microcystic spaces (false ducts) filled with basophilic mucoid or hyaline basement membrane-like material (Fig. 1.2.2)



  3. Two cell types: ductal and myoepithelial. The myoepithelial cells predominate. They are monotonous and basaloid and have hyperchromatic, angulated nuclei with indistinct nucleoli and small amounts of clear to eosinophilic cytoplasm. The ducts are often subtle and are comprised of cuboidal cells with eosinophilic cytoplasm (Fig. 1.2.2)



  4. Sometimes, the proportion of ducts to myoepithelial cells may be higher. These areas may closely resemble epithelial-myoepithelial carcinoma (Fig. 1.2.3)



  5. Highly infiltrative, with perineural invasion very commonly identified



  6. Tumor necrosis and elevated mitotic rates are uncommon but are more common in tumors with a predominant solid pattern




  1. Tightly coupled biphasic tumor cell population with ducts surrounded by a row of myoepithelial cells, typically with clear cytoplasm (Fig. 1.2.4)



  2. Cribriform growth is absent or, at most, very focal



  3. Compared to adenoid cystic carcinoma, tumor cells exhibit nuclei with more open chromatin and more prominent nucleoli (Fig. 1.2.5)



  4. Ductal cells are usually evident, but in some cases, the myoepithelial cell component can overgrow the ducts in a sheetlike manner (Fig. 1.2.6)



  5. Often relatively circumscribed, though infiltrative growth is present at least focally in the form of nodular growth or invasion of benign tissues (Fig. 1.2.7). Perineural invasion may be seen but less frequently than in adenoid cystic carcinoma



  6. Tumor necrosis and elevated mitotic rates are not seen, except in rare cases of highgrade transformation


Special studies




  • Actin, calponin, S100, p63, and p40 highlight myoepithelial cells, while c-kit and EMA typically stain ductal component



  • Approximately 50% of adenoid cystic carcinomas harbor a (6;9) translocation resulting in MYB-NFIB gene fusion




  • Actin, calponin, S100, p63, and p40 highlight myoepithelial cells, while c-kit and EMA typically stain ductal component



  • Negative for MYB rearrangements. Some cases harbor RAS mutations


Treatment


Wide local resection with adjuvant radiotherapy. Neck dissection not usually performed because lymph node metastases are uncommon. Chemotherapeutic agents are generally ineffective


Surgical excision. Adjuvant radiation considered if there are aggressive histologic features (e.g., perineural invasion, large tumor size)


Prognosis


Patients have a good 5-year survival (75%-80%) but poor 15-year survival (25%-30%) due to slow but relentless growth. Tumors metastasize to lung, bone, liver, and brain. Tumors with a predominantly solid pattern are more aggressive


Good. Recurrences and metastases are uncommon







Figure 1.2.1 Adenoid cystic carcinoma with an infiltrative collection of tubules and cribriform structures.






Figure 1.2.2 Adenoid cystic carcinoma with cribriform growth. There is a true duct (center) with eosinophilic cytoplasm, numerous pseudoducts, and a predominance of myoepithelial cells with dark, angulated nuclei.







Figure 1.2.3 Adenoid cystic carcinomas are comprised of true ductal cells and myoepithelial cells. In this tumor, the eosinophilic ductal cells are surrounded by a zone of clear myoepithelial cells in a way that resembles epithelial-myoepithelial carcinoma. The basophilic stromal matrix is characteristic of adenoid cystic carcinoma.






Figure 1.2.4 Epithelial-myoepithelial carcinoma with numerous eosinophilic ducts that are tightly coupled with a surrounding layer of myoepithelial cells with abundant clear cytoplasm.






Figure 1.2.5 Epithelial-myoepithelial carcinoma with myoepithelial cells demonstrating large nuclei with open chromatin and prominent nucleoli.






Figure 1.2.6 Epithelial-myoepithelial carcinoma with a predominance of myoepithelial cells.






Figure 1.2.7 Epithelial-myoepithelial carcinoma demonstrating irregular infiltration intro surrounding fat.



1.3 ADENOID CYSTIC CARCINOMA VS. BASALOID VARIANT OF SQUAMOUS CELL CARCINOMA


















































Adenoid Cystic Carcinoma


Basaloid variant of Squamous Cell Carcinoma


Age


Typically adults, peak incidence in sixth decade


Adults, peak in seventh decade


Location


Parotid gland is most common (40%-50%) but may arise in any major or minor salivary gland


Mucosal head and neck sites, most commonly larynx. Does not arise the major salivary glands, though rarely may involve them by metastatic spread


Symptoms


Slowly growing swelling, sometimes pain or paralysis due to perineural invasion. Other site-specific symptoms in minor salivary locations (e.g., nasal obstruction or epistaxis for sinonasal tumors)


Depends on site. In larynx, patients present with hoarseness and dysphagia


Signs


Palpable nodules that may become fixed to surrounding tissues


Ulcer and ill-defined mucosal-based mass


Etiology


Unknown


Strongly related to tobacco and alcohol consumption


Histology




  1. Variable mixture of tubules, cribriform structures, and solid nests (Fig. 1.3.1)



  2. Cribriform nests have cylindromatous microcystic spaces (false ducts) (Fig. 1.3.2)



  3. Two cell types: ductal and myoepithelial. The myoepithelial cells predominate; they are monotonous, basaloid, and have hyperchromatic, angulated nuclei with indistinct nucleoli and small amounts of clear to eosinophilic cytoplasm. The ducts are often subtle and are comprised of cuboidal cells with eosinophilic cytoplasm (Fig. 1.3.2)



  4. Squamous differentiation is absent



  5. Highly infiltrative. Perineural invasion is very common



  6. Tumor necrosis and elevated mitotic rates are uncommon but are more common in tumors with a predominant solid pattern




  1. Rounded nests of cells separated by thin lines of hyalinized stroma, creating a jigsaw puzzle-like pattern (Fig. 1.3.5)



  2. Frequent deposition of hyaline basement membrane-like material, creating pseudoglandular spaces and a cribriformlike appearance (Fig. 1.3.6)



  3. No true ducts



  4. Nests exhibit peripheral palisading, and tumor cells have high nuclear to cytoplasmic ratios



  5. Squamous differentiation is present within the tumor itself where it is often abrupt or in the form of overlying squamous cell carcinoma in situ (Fig. 1.3.7)



  6. Highly infiltrative. Perineural invasion is very common



  7. Tumor necrosis and elevated mitotic rates are present


Special studies




  • Actin, calponin, p63, S100, and p40 highlight myoepithelial cells, while c-kit and EMA typically highlight the ductal component (Figs. 1.3.3 and 1.3.4)



  • Approximately 50% of adenoid cystic carcinomas harbor a (6;9) translocation resulting in MYB-NFIB gene fusion




  • The tumor is diffusely positive for p63, CK5/6, and CK903 (Fig. 1.3.8). S100 and actin are negative. C-kit may be positive



  • Negative for (6;9) translocation


Treatment


Wide local resection with adjuvant radiotherapy. Neck dissection not usually performed because lymph node metastases are uncommon. Chemotherapeutic agents are generally ineffective


Surgery, radiotherapy, and chemotherapy. Neck dissection often performed, as nodal metastases are common


Prognosis


Patients have a good 5-year survival (75%-80%) but poor 15-year survival (25%-30%) due to slow but relentless growth. Tumors metastasize to lung, bone, liver, and brain. Tumors with a predominantly solid pattern are more aggressive


Poor. Basaloid variant appears to be more aggressive than conventional squamous cell carcinoma







Figure 1.3.1 Adenoid cystic carcinoma growing as cribriform and solid nests of basaloid cells.






Figure 1.3.2 Adenoid cystic carcinoma consisting predominantly of myoepithelial cells characterized by hyperchromatic and angulated nuclei. They form rounded cylindromatous (pseudoglandular) spaces. A few true ducts lined by cells with eosinophilic cytoplasm are also present.







Figure 1.3.3 Adenoid cystic carcinomas are positive for p63 in a patchy pattern that spares the ductal cells.






Figure 1.3.4 Adenoid cystic carcinomas are usually positive for one or more myoepithelial cell markers such as S100.






Figure 1.3.5 Basaloid variant of squamous cell carcinoma growing as rounded nests of cells separated by thin lines of hyalinized stroma, creating a jigsaw puzzle-like pattern.






Figure 1.3.6 Basaloid variant of squamous cell carcinoma with central comedo necrosis and pseudoglandular spaces created by the deposition of hyaline basement membrane-like material. Evidence of squamous differentiation is seen as an adjacent focus of keratinizing squamous cell carcinoma and as abrupt keratinization with a basaloid nest (inset).






Figure 1.3.7 Basaloid variant of squamous cell carcinoma with a focus of abrupt keratinization. Evidence of keratinization helps distinguish the basaloid variant of squamous cell carcinoma from the solid variant of adenoid cystic carcinoma.






Figure 1.3.8 Basaloid variant of squamous cell carcinoma is typically positive for p63 in a diffuse pattern.



1.4 ADENOSQUAMOUS CARCINOMA VS. MUCOEPIDERMOID CARCINOMA, HIGH GRADE

















































Adenosquamous Carcinoma


Mucoepidermoid Carcinoma, High Grade


Age


Adults, peak in seventh and eighth decades


Wide age range, with peak in second decade


Location


Almost always mucosal sites, especially larynx, oral cavity, and oropharynx. Cases in the major salivary glands very rare


Most frequently involves parotid gland but may be encountered in submandibular gland or minor salivary glands (especially intraoral)


Symptoms


Dependent on site. In larynx, hoarseness, dysphagia, and hemoptysis


Slow-growing mass, may be painful


Signs


Irregular fleshy mass, often large and exophytic


Poorly circumscribed mass, sometimes with cervical lymphadenopathy


Etiology


Association with cigarette smoking. A subset of oropharyngeal and nasal cases harbor high-risk HPV


Unknown. Consistently negative for HPV


Histology




  1. Highly infiltrative, unencapsulated proliferation of squamous nests and tumor ducts (Fig. 1.4.1)



  2. Squamous and glandular components are typically separate and distinct, with the glandular component often in the deeper portions of the tumor (Figs. 1.4.2 and 1.4.3)



  3. Squamous component often demonstrates abundant keratinization (Fig. 1.4.1)



  4. Dysplasia or carcinoma in situ of the overlying surface epithelium often seen (Fig. 1.4.2)



  5. Marked cellular atypia, with frequent mitotic figures in both squamous and glandular components




  1. Highly infiltrative, unencapsulated proliferation of squamoid and intermediate cells (Fig. 1.4.5)



  2. Ducts and mucinous cells are scarce, scattered among the squamoid and intermediate cells, and often difficult to recognize without special stains (Fig. 1.4.6)



  3. Keratinization is absent or very limited



  4. Not associated with surface squamous dysplasia



  5. Moderate-to-marked cellular atypia, with frequent mitotic figures



  6. Focal necrosis may be present but is not prominent



  7. A lower-grade component of mucoepidermoid carcinoma may be seen


Special studies




  • The squamous component is diffusely positive for squamous markers p63, p40, and CK5/6



  • Glandular component is negative for p63, p40, and CK5/6



  • Mucin stains highlight intraluminal mucin in the glandular component (Fig. 1.4.4)



  • A subset of oropharyngeal and nasal cases harbor high-risk HPV



  • Negative for MAML2 rearrangements




  • Diffusely positive for squamous markers p63, p40, and CK5/6



  • Mucin stains are positive in scattered mucinous cells (Fig. 1.4.7)



  • Consistently negative for HPV



  • (30%-50%) harbor MAML2 rearrangements (CRTC1 and CRTC3 are the most common partner genes)


Treatment


Similar to mucosal squamous cell carcinoma: surgical excision usually with adjuvant radiation and chemotherapy


Surgical excision and radiotherapy, often with neck dissection. Chemotherapy occasionally used with recurrent or disseminated disease


Prognosis


Poor, with 5-year survivals of 20%-40%


Poor, with 5-year survivals of 30%-50%








Figure 1.4.1 Adenosquamous carcinoma with two separate, distinct components: squamous cell carcinoma (top left) and adenocarcinoma (bottom right).






Figure 1.4.2 Adenosquamous carcinoma associated with squamous carcinoma in situ of the surface epithelium. The invasive portion of the tumor shows areas of obvious glandular differentiation.






Figure 1.4.3 Adenosquamous carcinoma exhibits marked cellular atypia in both the squamous (upper) and glandular (lower) tumor components.






Figure 1.4.4 In adenosquamous carcinomas, mucin stains highlight luminal mucin in the glandular component.







Figure 1.4.5 High-grade mucoepidermoid carcinoma composed of predominantly intermediate and squamoid cells. Mucinous cells may be difficult to appreciate in routinely stained sections.






Figure 1.4.6 High-grade mucoepidermoid carcinoma with a single mucin droplet in a nest of malignant squamoid cells.






Figure 1.4.7 In high-grade mucoepidermoid carcinomas, mucin stains (e.g., mucicarmine stain) can be helpful in highlighting the presence of mucinous cells.



1.5 BASAL CELL ADENOCARCINOMA VS. ADENOID CYSTIC CARCINOMA


















































Basal Cell Adenocarcinoma


Adenoid Cystic Carcinoma


Age


Adults, with peak in sixth and seventh decades


Typically adults, peak incidence in sixth decade


Location


Usually parotid gland, less commonly submandibular gland or minor salivary glands


Parotid gland is most common (40%-50%) but may arise in any major or minor salivary gland


Symptoms


Painless, slow-growing mass. Some (especially membranous subtype) may be multinodular. Patients may also have skin adnexal tumors


Slowly growing swelling, sometimes pain or paralysis due to perineural invasion. Other site-specific symptoms in minor salivary locations (e.g., nasal obstruction or epistaxis for sinonasal tumors)


Signs


Variably circumscribed, solid nodules


Palpable nodules that may become fixed to surrounding tissues


Etiology


A small subset present in the setting of familial/multiple cylindromatosis (Brooke-Spiegler) syndrome, an autosomal dominant hereditary disease


Unknown


Histology




  1. Invasive growth is present. The invasive edge is generally seen as rounded lobules with pushing borders (Fig. 1.5.1). Perineural invasion is not common but may be seen



  2. Growth in nests and trabecula with peripheral palisading of tumor nuclei surrounding paler cells in the center (Fig. 1.5.2)



  3. Scattered ducts within the nests of basaloid cells are often present (Fig. 1.5.3)



  4. Tumor cells have minimal cytoplasm, round to oval nuclei with pale chromatin, and indistinct cell borders. They may demonstrate streaming or spindling



  5. The classic cribriform architecture of adenoid cystic carcinoma is absent



  6. In the membranous variant, eosinophilic basal lamina material is deposited within and around the tumor nests (Fig. 1.5.4). At times, this deposition may impart a cribriform pattern



  7. Cellular atypia and mitotic activity varies but is usually minimal




  1. Highly infiltrative growth. Perineural invasion is a common finding (Fig. 1.5.5)



  2. Mixed growth patterns including tubular, cribriform, and solid (Figs. 1.5.6 and 1.5.7)



  3. The cribriform pattern is the most common, with cylindromatous microcystic spaces (false ducts) filled with basophilic mucoid or hyaline basement membrane-like material (Fig. 1.5.6)



  4. Adenoid cystic carcinomas with a predominant solid growth pattern are most likely to be confused with a basal cell adenocarcinoma (Figs. 1.5.7 and 1.5.9)



  5. The predominant cell type, the myoepithelial cell, has uniformly angulated hyperchromatic nuclei with indistinct nucleoli. The cytoplasm is scant and clear to eosinophilic (Fig. 1.5.8)



  6. Tumor necrosis and elevated mitotic rates are uncommon, but the solid form may exhibit increasing degrees of cellular atypia and mitotic activity (Fig. 1.5.9)


Special studies




  • The tumor is variably positive for p63, S100, actin, calponin, and GFAP, supporting myoepithelial differentiation of some of the cells. C-kit highlights ducts



  • Negative for MYB-NFIB gene fusion




  • Actin, calponin, S100, p63, and p40 highlight the myoepithelial cells, while c-kit and EMA highlight the ductal cells



  • Approximately 50% of adenoid cystic carcinomas harbor a (6;9) translocation resulting in MYB-NFIB gene fusion


Treatment


Surgical excision, usually without radiotherapy or lymph node dissection


Wide local resection with adjuvant radiotherapy. Routine neck dissection is not usually performed as lymph node metastases are uncommon. Chemotherapeutic agents are generally ineffective


Prognosis


Good. It may recur locally but regional and distant metastases are rare


Patients have a good 5-year survival (75%-80%) but poor 15-year survival (25%-30%) due to slow but relentless growth. Tumors metastasize to lung, bone, liver, and brain. Tumors with a predominantly solid pattern are more aggressive







Figure 1.5.1 Basal cell adenocarcinomas infiltrate surrounding tissues as rounded pushing nodules.






Figure 1.5.2 Basal cell adenocarcinomas show a nested pattern of growth with some suggestion of palisading at the periphery of the lobules. Cellular atypia and mitotic activity are often minimal.







Figure 1.5.3 The tumor cells of basal cell adenocarcinoma have minimal cytoplasm, round to oval nuclei with pale chromatin, and small nucleoli. Squamous nests and ductal formations are often encountered in the center of the basaloid lobules.






Figure 1.5.4 Basal cell adenocarcinoma with intra- and intercellular deposition of eosinophilic basal lamina material.






Figure 1.5.5 Adenoid cystic carcinomas are highly infiltrative carcinomas and almost always exhibit perineural invasion.






Figure 1.5.6 Adenoid cystic carcinoma with a mixture of tubules and cribriform structures. Cylindromatous microcystic spaces filled with basophilic mucoid or hyaline basement membrane-like material are characteristic findings.







Figure 1.5.7 With loss of cribriform structures and the presence of more solid growth, adenoid cystic carcinoma can be easily confused with basal cell adenocarcinoma.






Figure 1.5.8 Adenoid cystic carcinoma with tumor cells that have clear cytoplasm and hyperchromatic, angulated nuclei with no nucleoli. The cylindromatous spaces are filled with a basophilic mucoid material.






Figure 1.5.9 The solid variant of adenoid cystic carcinoma exhibits high cellularity and increased cytologic atypia.



1.6 BASAL CELL ADENOMA VS. BASAL CELL ADENOCARCINOMA

















































Basal Cell Adenoma


Basal Cell Adenocarcinoma


Age


Adults, with peak in sixth and seventh decades


Adults, with peak in sixth and seventh decades


Location


Usually parotid gland, less commonly submandibular gland or minor salivary glands


Usually parotid gland, less commonly submandibular gland or minor salivary glands


Symptoms


Painless, slow-growing mass. Some (especially membranous subtype) may be multinodular. Patients may also have skin adnexal tumors


Painless, slow-growing mass. Some (especially membranous subtype) may be multinodular. Patients may also have skin adnexal tumors


Signs


Well-circumscribed, solid nodules


Variably circumscribed, solid nodules


Etiology


A small subset present in the setting of familial/multiple cylindromatosis (Brooke-Spiegler) syndrome, an autosomal dominant hereditary disease


A small subset present in the setting of familial/multiple cylindromatosis (Brooke-Spiegler) syndrome, an autosomal dominant hereditary disease


Histology




  1. Well-circumscribed, often encapsulated proliferation of basaloid cells. Invasive growth is absent (Fig. 1.6.1)



  2. Growth in nests and trabecula with peripheral palisading of tumor nuclei surrounding paler cells in the center (Fig. 1.6.2)



  3. Tumor cells have minimal cytoplasm, round to oval nuclei, and indistinct cell borders. They may demonstrate streaming or spindling (Fig. 1.6.2)



  4. Scattered ducts are usually seen (Fig. 1.6.3)



  5. In the membranous variant, eosinophilic basal lamina material is deposited within and around the tumor nests (Fig. 1.6.4)



  6. Minimal cellular atypia and mitotic activity




  1. Invasive growth is present. The invasive edge is often rounded and pushing (Fig. 1.6.5). Perineural invasion is not common but may be seen (Fig. 1.6.6)



  2. Cellular atypia and mitotic activity varies but is usually minimal (Fig. 1.6.7)



  3. Aside from invasion, it may closely resemble basal cell adenoma. The basaloid cells exhibit palisading at the periphery of the tumor lobules, scattered ducts are often present within the lobules, and deposition of basement membrane-like material may be present


Special studies


Immunohistochemical stains for myoepithelial markers (p63, S100, actin, calponin, GFAP) highlight a variable number of positive cells. C-kit highlights the ducts


Immunohistochemical stains for myoepithelial markers (p63, S100, actin, calponin, GFAP) highlight a variable number of positive cells. C-kit highlights the ducts


Treatment


Surgical excision only


Surgical excision, usually without radiotherapy or lymph node dissection


Prognosis


Excellent. Low rate of tumor recurrence (except membranous variant, which recurs as often as 50%)


Good. May recur locally but regional and distant metastases are rare








Figure 1.6.1 Basal cell adenoma with a thin capsule and no invasive growth.






Figure 1.6.2 Basal cell adenoma with nests and trabeculae of basaloid cells that often palisade at the periphery and stream within the center of the nests.






Figure 1.6.3 Ductal lumina are often observed between the basaloid cells. They are prominent in the tubular form of basal cell adenoma.






Figure 1.6.4 The membranous form of basal cell adenoma, abundant hyaline material is deposited in and around the islands of basal cells.







Figure 1.6.5 Basal cell adenocarcinoma demonstrating rounded islands of basal cells extending into fat. The presence of invasion is a key feature in distinguishing basal cell carcinoma from basal cell adenoma.






Figure 1.6.6 Basal cell adenocarcinoma with perineural invasion.






Figure 1.6.7 Basal cell adenocarcinoma exhibiting uniform, elongated cells with mild atypia and an elevated mitotic rate.



1.7 BASAL CELL ADENOMA VS. CANALICULAR ADENOMA

















































Basal Cell Adenoma


Canalicular Adenoma


Age


Adults, with peak in sixth and seventh decades


Adults, peak in fifth to seventh decades, more common in women


Location


Usually parotid gland, less commonly submandibular gland or minor salivary glands


Almost exclusively oral cavity with a strong predilection for the upper lip


Symptoms


Painless, slow-growing mass. Some (especially membranous subtype) may be multinodular. Patients may also have skin adnexal tumors


Asymptomatic or painless nodule


Signs


Well-circumscribed, nontender mass


Well-circumscribed, nontender mass. Occasionally multifocal


Etiology


A small subset present in the setting of familial/multiple cylindromatosis (Brooke-Spiegler) syndrome, an autosomal dominant hereditary disease


Unknown


Histology




  1. Well-circumscribed, often encapsulated proliferation of basaloid cells



  2. Growth in nests and trabecula with a fibrovascular or collagenized stroma



  3. Tumor cells have minimal cytoplasm, round to oval nuclei, and indistinct cell borders. They may demonstrate streaming or spindling



  4. Scattered ducts are usually seen. The presence of elongated tubular structures is well developed in the tubulotrabecular form of basal cell adenoma (Figs. 1.7.1 and 1.7.2)



  5. No significant nuclear atypia or mitotic activity




  1. Well-circumscribed, often encapsulated proliferation of basaloid cells



  2. Growth in double columns of cells forming interconnecting canals and tubules set in a loose and sparsely cellular myxoid stroma (Figs. 1.7.3 and 1.7.4)



  3. Tumor cells are uniformly aligned and columnar (Fig. 1.7.4)



  4. No scattered ducts



  5. No significant nuclear atypia or mitotic activity


Special studies


Immunohistochemical stains for myoepithelial markers (p63, S100, actin, calponin, GFAP) highlight a variable number of positive cells. C-kit highlights the ducts


One cell type, diffusely positive for S100 (Fig. 1.7.5)


Treatment


Surgical excision


Surgical excision


Prognosis


Excellent. Low rate of tumor recurrence


Excellent. Low rate of tumor recurrence








Figure 1.7.1 Basal cell adenoma with a prominence of branching tubular formations (tubulotrabecular form of basal cell adenoma). In contrast to canalicular adenoma, the stroma is more cellular.






Figure 1.7.2 In this tubulotrabecular form of basal cell adenoma, some of the trabeculae are solid, and the cells lack the columnar appearance seen in canalicular adenomas.






Figure 1.7.3 Canalicular adenoma with double rows of columnar cells forming anastomosing canaliculi. The stroma is loose and paucicellular.






Figure 1.7.4 Canalicular adenoma is composed of a single layer of uniform, columnar cells.






Figure 1.7.5 Canalicular adenoma with diffuse immunostaining for S100.



1.8 BASAL CELL ADENOMA VS. PLEOMORPHIC ADENOMA

















































Basal Cell Adenoma


Pleomorphic Adenoma


Age


Adults, with peak in sixth and seventh decades


Wide age range, mean approximately 45 years


Location


Usually parotid gland, less commonly submandibular gland or minor salivary glands


Usually parotid gland (80%-90%), followed by submandibular gland and minor salivary glands


Symptoms


Painless, slow-growing mass. Some (especially membranous subtype) may be multinodular. Patients may also have skin adnexal tumors


Painless slow-growing mass. Multinodularity encountered with tumor recurrence


Signs


Well-circumscribed, nontender mass


Well-circumscribed, nontender mass


Etiology


A small subset present in the setting of familial/multiple cylindromatosis (Brooke-Spiegler) syndrome, an autosomal dominant hereditary disease


Unknown


Histology




  1. Well-circumscribed, often encapsulated proliferation of basaloid cells (Fig. 1.8.1)



  2. Growth in nests and trabecula with peripheral palisading of tumor nuclei surrounding paler cells in the center (Fig. 1.8.2)



  3. Tumor cells have minimal cytoplasm, round to oval nuclei, and indistinct cell borders. They may demonstrate streaming or spindling



  4. Scattered ducts are usually seen



  5. The stroma between the tumor nests varies from cellular to hyalinized, but it generally lacks the loose chondromyxoid stroma of a pleomorphic adenoma (Fig. 1.8.3)




  1. Well-circumscribed, often encapsulated neoplasm comprised of epithelial and modified myoepithelial elements in a stroma that varies from hyalinized to myxoid to chondroid (Fig. 1.8.4)



  2. The epithelial cells show a wide range of cell types including ductal, squamous, oncocytic, and mucinous types. Most commonly, they form ductal structures with eosinophilic secretory material (Fig. 1.8.5)



  3. The ductal cells are often surrounded by myoepithelial cells that merge into the stroma (Fig. 1.8.5). The myoepithelial cells also show a wide variation in cell types, ranging from epithelioid to spindled to plasmacytoid to clear to chondroid



  4. The mesenchymal-like component varies from hyalinized to myxoid to chondroid to osseous (Figs. 1.8.4 and 1.8.5)



  5. The proportion of stroma to epithelium is highly variable (Figs. 1.8.4, 1.8.5, 1.8.6 and 1.8.7)



  6. Stroma-poor areas may resemble basal cell adenoma (Fig. 1.8.6)


Special studies


Immunohistochemical stains for myoepithelial markers (p63, S100, actin, calponin, GFAP) highlight a variable number of positive cells. C-kit highlights the ducts


Immunohistochemical stains for myoepithelial markers (p63, S100, actin, calponin, GFAP) highlight a variable number of positive cells. C-kit highlights the ducts


Treatment


Surgical excision


Surgical excision


Prognosis


Excellent. Low rate of tumor recurrence (except membranous variant, which recurs as often as 50%). Malignant transformation almost never occurs


Excellent. May recur if incompletely excised. May rarely undergo malignant transformation (carcinoma ex-pleomorphic adenoma)








Figure 1.8.1 Basal cell adenoma comprised of a circumscribed and encapsulated proliferation of basaloid cells.






Figure 1.8.2 Basal cell adenoma with nests and trabeculae of basaloid cells that often palisade at the periphery and stream within the center of the nests.






Figure 1.8.3 The cellularity of the stroma in basal cell adenomas is variable, but they lack the abundant loose chondromyxoid stroma that characterizes most pleomorphic adenomas. In this example, the stroma is comprised of a cellular proliferation of spindled cells.






Figure 1.8.4 Pleomorphic adenomas are circumscribed, often encapsulated neoplasms comprised of epithelial and modified myoepithelial elements in a stroma that is often loose and myxoid.







Figure 1.8.5 The epithelial cells of pleomorphic adenomas can take on many forms, but they most commonly form ducts. They are intimately associated with myoepithelial cells that merge with a chondromyxoid stroma.






Figure 1.8.6 Stromal poor areas of a pleomorphic adenoma may resemble basal cell adenoma.






Figure 1.8.7 Same tumor as shown in Figure 1.8.6. Thorough microscopic evaluation can usually disclose areas where the loose stroma of pleomorphic adenoma is better developed.



1.9 CARCINOMA EX-PLEOMORPHIC ADENOMA VS. INFARCTED PLEOMORPHIC ADENOMA


















































Carcinoma Ex-Pleomorphic Adenoma


Infarcted Pleomorphic Adenoma


Age


Adults, peak in sixth and seventh decades (about a decade later than pleomorphic adenoma)


Wide age range, mean approximately 45 years


Location


Usually parotid glands, rarely in submandibular and minor salivary glands


Usually parotid gland (80%-90%), followed by submandibular gland and minor salivary glands


Symptoms


Rapidly growing mass, often in the setting of a long-standing mass or multiple recurrent pleomorphic adenomas


Painless slow-growing mass. Most patients have had a prior fine-needle aspiration


Signs


Largely dependent on the degree of invasion


Nontender mass


Etiology


Malignant transformation of a pleomorphic adenoma


Infarction usually following a fine-needle aspiration or core biopsy


Histology




  1. Virtually any salivary gland carcinoma may arise in a pleomorphic adenoma, but salivary duct carcinoma is the most common



  2. The carcinoma may be confined by the capsule of the pleomorphic adenoma (noninvasive type), it may demonstrate limited (<1.5 mm) invasion through the tumor capsule (minimally invasive type), or it may more widely (more than 1.5 mm) invade beyond the tumor capsule (widely invasive type) (Fig. 1.9.1)



  3. The carcinomatous component is often (but not always) a high-grade adenocarcinoma characterized by malignant cellular features (nuclear enlargement, pleomorphism, prominent nucleoli, an elevated mitotic rate) and necrosis (Fig. 1.9.2)




  1. Central zone of tumor infarction with associated hemorrhage and fibrin (Fig. 1.9.4)



  2. Proliferative squamous metaplasia, which is usually inflamed and often exhibits reactive atypia, mitotic figures and prominent nucleoli. This should not be misinterpreted as carcinoma (Figs. 1.9.5, 1.9.6, 1.9.7 and 1.9.8)



  3. Viable pleomorphic adenoma is usually present at the periphery of the tumor, often with a zone of transition between metaplastic and nonmetaplastic ductal epithelium (Fig. 1.9.8)


Special studies


Salivary duct carcinoma is the most common type of carcinoma encountered in a carcinoma ex-pleomorphic adenoma, and it is positive for gross cystic disease fluid protein (GCDFP) and androgen receptor. In some cases of early noninvasive carcinoma ex-pleomorphic adenoma, myoepithelial cell markers (e.g., S100, p63) can demonstrate that the carcinoma is entirely intraductal (Fig. 1.9.3)


None helpful in this differential diagnosis


Treatment


Depends on the degree of invasion and the type and grade of the carcinoma. Noninvasive carcinomas are treated with excision alone, while widely invasive high-grade carcinomas are treated with aggressive multimodality therapy


Surgical excision


Prognosis


Depends on the degree of invasion and on the type and grade of the carcinoma. Noninvasive and minimally invasive carcinomas have an excellent prognosis, while widely invasive high-grade carcinomas have a poor prognosis


Excellent







Figure 1.9.1 Invasive carcinoma ex-pleomorphic adenoma (right) infiltrating into periparotid soft tissues. Although most of the pleomorphic adenoma has been overridden by the carcinoma, its chondroid stroma is still focally present (left).






Figure 1.9.2 Although the carcinomatous component may be either low or high grade, most are high-grade adenocarcinomas with features of salivary duct carcinoma.






Figure 1.9.3 Carcinoma ex-pleomorphic adenoma, noninvasive type, with salivary duct carcinoma contained within the ductal system and entirely surrounded by actin-positive myoepithelial cells (immunohistochemical stain for smooth muscle actin).






Figure 1.9.4 Infarcted pleomorphic adenoma with a central zone of coagulative necrosis.







Figure 1.9.5 Infarcted pleomorphic adenoma with a central zone of infarction (left) surrounded by a zone of highly proliferative squamous metaplasia (center). The zone of squamous metaplasia may be mistaken for squamous cell carcinoma.






Figure 1.9.6 Adjacent to the zone of infarction, the ducts of pleomorphic adenoma are filled with metaplastic squamous cells.






Figure 1.9.7 The zones of proliferative squamous metaplasia may exhibit dyskeratosis and cellular atypia.






Figure 1.9.8 Thorough inspection will usually disclose areas of conventional pleomorphic adenoma. In this area, the zone of squamous metaplasia shows transition with the nonmetaplastic ductal epithelium.



1.10 CARCINOMA EX-PLEOMORPHIC ADENOMA VS. RECURRENT PLEOMORPHIC ADENOMA


















































Carcinoma Ex-Pleomorphic Adenoma


Recurrent Pleomorphic Adenoma


Age


Adults, peak in sixth and seventh decades (about a decade later than pleomorphic adenoma)


Recurrent pleomorphic adenoma presents on average 7-10 years after excision of prior pleomorphic adenoma


Location


Usually parotid glands, rarely in submandibular and minor salivary glands


Occurs at the site of a previously excised pleomorphic adenoma, usually parotid gland


Symptoms


Rapidly growing mass, often in the setting of a long-standing mass or multiple recurrent pleomorphic adenomas


Multinodular mass at prior surgical site


Signs


Large irregular mass, sometimes with regional lymphadenopathy


Multinodular growth along at prior surgical site


Etiology


Malignant transformation of a pleomorphic adenoma


Tumor rupture at time of surgery leading to seeding of the tumor along surgical site or incomplete initial excision


Histology




  1. Virtually any salivary gland carcinoma may arise in a pleomorphic adenoma, but salivary duct carcinoma is the most common (Fig. 1.10.1)



  2. The carcinoma may be confined by the capsule of the pleomorphic adenoma (noninvasive type), it may demonstrate limited (<1.5 mm) invasion through the tumor capsule (minimally invasive type), or it may more widely (more than 1.5 mm) invade beyond the tumor capsule (widely invasive type)



  3. The carcinomatous component is often (but not always) a high-grade adenocarcinoma characterized by malignant cellular features (nuclear enlargement, pleomorphism, prominent nucleoli, a high mitotic rate) and necrosis (Fig. 1.10.2)




  1. Often demonstrates a multinodular pattern throughout the salivary gland and adjacent soft tissues, mimicking invasive growth (Fig. 1.10.3)



  2. Despite its alarming pseudoinvasive growth, it does not exhibit cellular features of malignancy (Fig. 1.10.4)



  3. The tumor cells have uniform bland nuclei, and the mitotic rate is not elevated (Fig. 1.10.4)



  4. Often arise in a background scarring, foreign body reaction, and traumatic neuromas reflecting prior surgery (Fig. 1.10.5)


Special studies


Salivary duct carcinoma is the most common type of carcinoma encountered in a carcinoma ex-pleomorphic adenoma, and it is positive for gross cystic disease fluid protein (GCDFP) and androgen receptor. In some cases of early noninvasive carcinoma ex-pleomorphic adenoma, myoepithelial cell markers (e.g., S100, p63) can demonstrate that the carcinoma is entirely intraductal


None helpful in this differential diagnosis


Treatment


Depends on the degree of invasion and the type and grade of the carcinoma. Noninvasive carcinomas are treated with excision alone, while widely invasive high-grade carcinomas are treated with aggressive multimodality therapy


Surgical excision. Radiotherapy may be employed for unresectable residual disease to improve local control


Prognosis


Depends on the degree of invasion and on the type and grade of the carcinoma. Noninvasive and minimally invasive carcinomas have an excellent prognosis, while widely invasive high-grade carcinomas have a poor prognosis


Patients with one recurrence cured in up to 80%-90%. Chance for cure falls with each subsequent recurrence. Risk of malignant transformation to carcinoma ex-pleomorphic adenoma also increases with each recurrence







Figure 1.10.1 Carcinoma ex-pleomorphic adenoma with a high-grade salivary duct carcinoma (bottom) arising in association with a chondroid stroma-rich pleomorphic adenoma (top).






Figure 1.10.2 Carcinoma ex-pleomorphic adenoma, with carcinoma demonstrating not only invasion into fat but also frankly malignant cellular features.







Figure 1.10.3 Recurrent pleomorphic adenoma, with multiple nodules of stroma-rich pleomorphic adenoma scattered throughout the fat in a pseudoinvasive manner.






Figure 1.10.4 Recurrent pleomorphic adenoma, with a mixture of stromal and epithelial components that exhibit no cellular atypia. The cellularity of the various nodules may be highly variable, but most nodules have an abundant myxoid stroma.






Figure 1.10.5 The recurrent nodules of pleomorphic adenoma often arise in a background of changes reflecting prior surgery such as scarring. In this example, the nodule is arising next to a traumatic neuroma characterized by proliferating nerve twiglets.



1.11 CLEAR CELL ONCOCYTOMA/NODULAR ONCOCYTIC HYPERPLASIA VS. METASTATIC RENAL CELL CARCINOMA

















































Clear Cell Oncocytoma/Nodular Oncocytic Hyperplasia


Metastatic Renal Cell Carcinoma


Age


Adults, peak in sixth decade


Typically elderly, more common in men


Location


Almost always parotid gland, rarely submandibular or minor salivary glands. Oncocytic hyperplasia is often bilateral


The salivary glands are not a frequent target of metastatic spread, but renal cell carcinoma is most common tumor type. Among salivary glands, the parotid gland is most commonly involved


Symptoms


Painless, slow-growing mass or masses


Painless mass


Signs


Single or multinodular process


Most, but not all, patients have a known history of renal cell carcinoma


Etiology


A minority of patients have a history of prior radiation therapy


Distant spread from a kidney primary


Histology




  1. Nodular proliferation of oncocytic cells growing as sheets, nests, and/or trabeculae, separated by thin fibrovascular septa (Fig. 1.11.1)



  2. The process may be uninodular (as in oncocytoma) or multinodular (as in nodular oncocytic hyperplasia)



  3. The oncocyte, characterized by abundant granular eosinophilic cytoplasm, is prone to cytoplasmic clearing (Figs. 1.11.2 and 1.11.3). Clear cell change may be focal or widespread throughout the entire lesion



  4. More conventional oncocytic areas often present (Fig. 1.11.5)



  5. Ductal formations commonly seen



  6. No blood lakes seen



  7. Only mild nuclear pleomorphism and mitotic figures are rare. No necrosis




  1. Single or multiple unencapsulated nodules of clear cells growing as sheets, nests, and/or trabeculae, separated by thin fibrovascular septa (Fig. 1.11.6)



  2. No oncocytic metaplasia in the background gland



  3. Ductal formations are not seen



  4. Follicles filled with blood (“blood lakes”) are common (Fig. 1.11.7)



  5. Variable degree of nuclear pleomorphism, mitotic activity, and necrosis


Special studies


Patchy positivity for p63, p40, and CK5/6 in a peripheral, basal distribution of tumor nests (Fig. 1.11.4). PAX8 is usually negative


Negative for p63. Positive for Pax8 (Fig. 1.11.8)


Treatment


Surgical excision alone


Excision may be done if a single metastasis. Metastatic clear cell renal cell carcinoma may also be treated with systemic agents like antiangiogenic agents or tyrosine kinase inhibitors


Prognosis


Excellent


Generally poor, though prognosis is better if the metastatic spread is solitary rather than widespread

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 23, 2018 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Salivary Glands

Full access? Get Clinical Tree

Get Clinical Tree app for offline access